Peter Balingit, MD
Director, Hospitalist Program
Dr. Balingit completed internal medicine residency training at Olive View-UCLA and joined the faculty in 2001 after receiving the Pramod Gan, M.D. award as best third year resident in medicine at Olive View.
His goal in overseeing the hospitalist rotation curriculum is to ensure senior residents gain proficiency in essential skills, including formulating evidence-based therapeutic approaches to management, time management and efficiency, competence in performing common bedside procedures, and utilization of inpatient clinical pathways to meet patient care benchmarks. He enjoys teaching techniques for invasive procedures such as thoracentesis, paracentesis, central venous catheter placement, lumbar puncture, and arthrocentesis. Additionally, he also attends on the inpatient ward teaching service for several months throughout the year.
To highlight the outstanding inpatient clinical experience at Olive View, Dr. Balingit has mentored residents and medical students in the authorship of numerous abstracts and case reports, and he has appeared on the nationally televised ABC News Primetime program to describe a case of periodic paralysis. Dr. Balingit’s clinical interests also include care of the terminally ill patient, and he is board-certified in hospice and palliative medicine.
In addition to his clinical duties, Dr. Balingit also has an interest studying novel therapies in the care of diabetic foot ulcers. He is principal investigator for two clinical trials currently being conducted at Olive View: Use of the dermaPACE™ (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care in the Treatment of Diabetic Foot Ulcers and Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial to Evaluate the Safety and Effectiveness of DSC127 [NorLeu3-Angiotensin (1-7)] in Treating Subjects With Diabetic Ulcers.
